Methylphenidate Controlled-Release Tablets and Rasburicase
Determining the interaction of Methylphenidate Controlled-Release Tablets and Rasburicase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: rasburicase
Brand name: Elitek, Fasturtec
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Controlled-Release Tablets-Rasburicase Intravenous
- Methylphenidate Controlled-Release Tablets-Rash Relief Antifungal
- Methylphenidate Controlled-Release Tablets-Rasuvo
- Methylphenidate Controlled-Release Tablets-Rasuvo injection
- Methylphenidate Controlled-Release Tablets-Ratio-Amoxi Clav 250f
- Methylphenidate Controlled-Release Tablets-Ratio-Clobetasol
- Rasburicase-Methylphenidate ER Capsules
- Rasburicase-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Rasburicase-Methylphenidate Extended-Release Chewable Tablets
- Rasburicase-Methylphenidate Extended-Release Oral Suspension
- Rasburicase-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Rasburicase-Methylphenidate Extended-Release Tablets